Loading clinical trials...
Loading clinical trials...
A Multicenter, Pilot Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant for the Treatment of Insomnia
Conditions
Interventions
LEM 5 mg
LEM 10 mg
Locations
17
United States
PACT
Glendale, Arizona, United States
Northern California Research Corp
Sacramento, California, United States
Artemis Institute For Clinical Research LLC - San Diego - ClinEdge - PPDS
San Diego, California, United States
SDS Clinical Trials, Inc.
Santa Ana, California, United States
Fleming Island Center For Clinical Research - ERN-PPDS
Fleming Island, Florida, United States
MD Clinical
Hallandale, Florida, United States
Start Date
July 15, 2019
Primary Completion Date
March 17, 2020
Completion Date
June 26, 2020
Last Updated
April 12, 2021
NCT06032377
NCT06181643
NCT06807086
NCT07429578
NCT05780814
NCT06348082
Lead Sponsor
Eisai Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions